de Wouters d’Oplinter, Alice
Verce, Marko
Huwart, Sabrina J. P.
Lessard-Lord, Jacob
Depommier, Clara
Van Hul, Matthias
Desjardins, Yves
Cani, Patrice D.
Everard, Amandine
Funding for this research was provided by:
Fonds De La Recherche Scientifique - FNRS (WELBIO-CR-2019C-02R, WELBIO-CR-2019S-03)
Article History
Received: 28 June 2022
Accepted: 20 March 2023
First Online: 28 April 2023
Declarations
:
: All mouse experiments were approved by the ethical committee for animal care of the Health Sector of the UCLouvain, Université catholique de Louvain under the specific numbers 2017/UCL/MD/005 and 2021/UCL/MD/060 and performed in accordance with the guidelines of the local ethics committee and in accordance with the Belgian Law of May 29, 2013, regarding the protection of laboratory animals (agreement number LA1230314).
: Not applicable
: P.D.C. was co founder of The Akkermansia Company and Enterosys, and A.E., P.D.C., and A.d.W.d.O. are owners of patents on gut microbes and metabolic diseases.